Paul Tudor Jones’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Paul Tudor Jones’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-21,836	Closed	-$268K	–	3108
2022 Q4	$268K	Buy	21,836 +31	+0.1%	+$739	0.01%	1981
2022 Q3	$716K	Buy	+21,805	New	+$616K	0.02%	1154

Paul Tudor Jones's CINC Position: Q1 2023 in Review

Paul Tudor Jones sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 21,836 shares — an estimated $268K sold.

Paul Tudor Jones first reported a position in CINC in Q3 2022 and held it in 2 quarters. The position peaked at $716K in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Paul Tudor Jones reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Paul Tudor Jones sold 21,836 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $268K.
Paul Tudor Jones first reported a position in CinCor Pharma, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Paul Tudor Jones's CinCor Pharma, Inc. Common Stock position peaked at $716K in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.